Digital Immunoassay for Biomarker Detection Based on Single-Particle Laser Ablation ICP MS
Open Access
- 24 June 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (26) , 13832-13839
Abstract
Single-particle (digital) immunoassays offer significantly lower limits of detection (LODs) than traditional immunoassays, making them suitable for the detection of low-abundance biomarkers. The most common approach for digital detection is based on counting individual labels. Here, we introduce a novel dot-blot particle-linked immunosorbent assay (PLISA) with digital readout utilizing laser ablation (LA) of photon upconversion nanoparticle (UCNP) labels from the nitrocellulose substrate. Compared to conventional LA, our approach allows desorption of intact nanoparticles and their precise counting by single-particle inductively coupled plasma mass spectrometry (SP ICP MS), thus counting individual UCNP-labeled immunocomplexes. Digital signal processing filters instrument noise and nanoparticle aggregates, minimizing potential errors. The immunoassay and LA SP ICP MS readout were optimized using human serum albumin, a kidney damage biomarker, as a model analyte, obtaining LODs of 0.18 and 0.12 ng/mL for the reference upconversion luminescence (UCL) and LA SP ICP MS readout, respectively. Building upon these optimized conditions, we developed PLISA for prostate-specific antigen, the key prostate cancer biomarker, with LODs of 2.4, 1.4, and 0.3 pg/mL for the UCL, analog, and digital LA SP ICP MS readout, respectively. The LOD in the sub-pg/mL range highlighted the advantage of particle counting and its ability to detect low-abundance biomarkers, as superior performance was achieved compared to the UCL and analog LA ICP MS readout. Finally, clinical serum samples of patients tested for prostate cancer were analyzed, and a strong correlation with the reference electrochemiluminescence method confirmed the potential of LA SP ICP MS for clinical diagnostics.Keywords
Funding Information
- Agentura Pro Zdravotnick? V?zkum Cesk? Republiky (NU22-05-00042)
- ?stav Analytick? Chemie, Akademie Ved Cesk? Republiky (68081715)
This publication has 48 references indexed in Scilit:
- Review of single-molecule immunoassays: Non-chip and on-chip AssaysAnalytica Chimica Acta, 2024
- Nanoparticle‐Based Bioaffinity Assays: From the Research Laboratory to the MarketAdvanced Materials, 2023
- Urea, salts, and Tween 20 influence on adsorption of IgG and Leishmania rNTPDase2 to nitrocelluloseAnalytical Biochemistry, 2022
- Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the LiteratureEuropean Urology Oncology, 2021
- Advances in Optical Single‐Molecule Detection: En Route to Supersensitive Bioaffinity AssaysAngewandte Chemie International Edition, 2019
- Based on ZnSe quantum dots labeling and single particle mode ICP-MS coupled with sandwich magnetic immunoassay for the detection of carcinoembryonic antigen in human serumAnalytica Chimica Acta, 2018
- Gold nanoparticles as labels for immunochemical analysis using laser ablation inductively coupled plasma mass spectrometryAnalytical and Bioanalytical Chemistry, 2018
- Bioimaging of metallothioneins in ocular tissue sections by laser ablation-ICP-MS using bioconjugated gold nanoclusters as specific tagsMicrochimica Acta, 2017
- Perspectives and challenges of photon-upconversion nanoparticles - Part I: routes to brighter particles and quantitative spectroscopic studiesAnalytical and Bioanalytical Chemistry, 2017
- Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugsAnalytical Biochemistry, 2010